Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With MET Exon 14–Mutant NSCLC

by Paola Cravero, MD, Nuno Vaz, MD, Biagio Ricciuti, MD, Sarah E. Clifford, MPH, Gianluca DiUbaldi, BS, BA, Dawn Drevers, RN, Kaitlin Morton, BS, Rebecca E. Rivenburgh, BS, Mizuki Nishino, MD, MPH, Mark M. Awad, MD, PhD
Published 2020-11-01